Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.41 USD | +0.51% | -3.21% | -17.01% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
Evolution of the average Target Price on Evolent Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Evolent Health, Inc.
Citigroup | |
Canaccord Genuity | |
JPMorgan Chase | |
JMP Securities | |
RBC Capital Markets | |
Truist Securities | |
UBS | |
Guggenheim | |
Stephens Inc. | |
Cowen | |
Goldman Sachs | |
Piper Sandler | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- EVH Stock
- Consensus Evolent Health, Inc.